These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3303804)

  • 21. Multidrug therapy in leprosy.
    Manglani PR; Arif MA
    J Indian Med Assoc; 2006 Dec; 104(12):686-8. PubMed ID: 17474286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and bacteriological assessment 8 years after triple-drug therapy for multibacillary leprosy in Senegal].
    Dousset-Faure I; Millan J; Decazes JM; Languillon J
    Acta Leprol; 1986; 4(4):465-72. PubMed ID: 3296618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience with the combination of clofazimine (Lamprene) and long-term steroid therapy in the treatment of leprosy.
    Hogerzeil LM
    Lepr India; 1976 Oct; 48(4 Suppl):718-21. PubMed ID: 1026809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term evaluation of immune status in leprosy patients undergoing multiple drug therapy.
    Vu TT; Hoang TL; Nguyen DQ; Ho ML; Nguyen DH; Le TH; Dang DT; Nguyen QA; Le TP; Tran HK
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):365-73. PubMed ID: 7963908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
    Mehta J; Gandhi IS; Sane SB; Wamburkar MN
    Lepr Rev; 1986; 57 Suppl 3():67-76. PubMed ID: 3573964
    [No Abstract]   [Full Text] [Related]  

  • 26. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Field application of combined therapy for infectious leprosy cases. A feasibility study in Bombay.
    Ganapati R; Revankar CR; Naik SS
    Lepr India; 1983 Jul; 55(3):485-9. PubMed ID: 6656206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of lepromatous Hansen disease with a rifampicine-isoprodian association (author's transl)].
    Colin M; de Montaigne E
    Med Trop (Mars); 1980; 40(2):157-9. PubMed ID: 6991851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-drug therapy in bacilliferous leprosy--two years experience.
    Kaur S; Sharma VK; Kumar B; Singh M; Kaur I
    Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
    Pattyn S; Grillone S
    Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent trends in chemotherapy of leprosy.
    Parikh DA; Maniar JK; Parikh AC; Ganapati R
    J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
    [No Abstract]   [Full Text] [Related]  

  • 32. Hansen's disease in Portugal: multibacillary patients treated between 1988 and 2003.
    Medeiros S; Catorze MG; Vieira MR
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):29-35. PubMed ID: 18713227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative study of the efficacy of WHO and IAL multidrug therapy regimens for leprosy--an in-vivo and in-vitro study.
    Revankar CR; Mahadevan PR; Ganapati R
    Indian J Lepr; 1986; 58(4):543-8. PubMed ID: 3553361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
    Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 36. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 38. [Polychemotherapy of leprosy in the Central African Republic, 1987].
    Desfontaine M; Somse P; Baquillon G; Kanda P; Limbassa J
    Acta Leprol; 1988; 6(5):47-55. PubMed ID: 3271377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of drug regimen in lepromatous leprosy--II.
    Ramu G; Sreevatsa
    Lepr India; 1983 Apr; 55(2):200-8. PubMed ID: 6195452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polytherapy in multibacillary leprosy patients in Nepal.
    Samuel NM; Samual S; Fairbairn T; Adiga RB
    Singapore Med J; 1985 Apr; 26(2):203-6. PubMed ID: 4035403
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.